Purification and use of glycomacropeptide for nutritional management of phenylketonuria

Journal of Food Science

Volumn 74, Issue 4, 2009, Pages

  LaClair, Caitlin E ^a   Ney, Denise M ^b   MacLeod, Erin L ^b   Etzel, Mark R ^a  

^a Dept of Food Science ^*  (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Foods; Glycomacropeptide; Phenylalanine; Phenylketonuria; Purification

Indexed keywords

AMINO ACID; CASEIN; CASEINOMACROPEPTIDE; LYSINE; PEPTIDE FRAGMENT; PHENYLALANINE;

ANIMAL; ARTICLE; CHEMISTRY; DIET THERAPY; FREEZE DRYING; HUMAN; ION EXCHANGE CHROMATOGRAPHY; ISOLATION AND PURIFICATION; MILK; NUTRITIONAL REQUIREMENT; PHENYLKETONURIA; ULTRAFILTRATION;

AMINO ACIDS; ANIMALS; CASEINS; CHROMATOGRAPHY, ION EXCHANGE; FREEZE DRYING; HUMANS; LYSINE; MILK; NUTRITIONAL REQUIREMENTS; PEPTIDE FRAGMENTS; PHENYLALANINE; PHENYLKETONURIAS; ULTRAFILTRATION;

EID: 65549098187     PISSN: 00221147     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3841.2009.01134.x     Document Type: Article

References (24)

1. Acosta P, Yanicelli S. 2001. Protocol 1-Phenylketonuria (PKU). In : Division RP, editor. The Ross metabolic formula system nutrition support protocols. 4th ed. Columbus, Ohio: Ross Laboratories, Ross Product Division.
2. [AOAC] Assn. of Official Analytical Chemists, Intl. 2005. Official methods of analysis of official analytical chemists. 18th ed. Gaithersburg, Md. : AOAC
3. Ayers J, Elgar D, Coolbear K, Pritchard M, inventors. 2003. Process for isolating glycomacropeptide from dairy products with a phenylalanine impurity of 0.5% w/w. U.S. patent 6,555,659.
4. Dziuba J, Minkiewicz P. 1996. Influence of glycosylation on micelle-stabilizing ability and biological properties of C-terminal fragments of cow's kappa-casein. Int Dairy J 6 (11-2 1017 44. (Pubitemid 27295328)
5. Etzel M. 2004. Manufacture and use of dairy protein fractions. J Nutr 996S 1002S. (Pubitemid 38456277)
6. [IOM] Inst. of Medicine. 2005. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Washington, D.C. : Natl. Academies Press.
7. Kawasaki Y, Dosako S, Shimatani M, Idota T, inventors; Snow Brand Milk Products Co., Ltd., assignee. 1994 Jan 18. Process for producing k-casein glycomacropeptides. U.S. patent 5,280,107.
8. Kerwin BA, Remmele RL. 2007. Protect from light: photodegradation and protein biologics. J Pharm Sci 96 (6 1468 79. (Pubitemid 46953763)
9. Mikkelsen T, Frokiaer H, Topp C, Bonomi F, Iametti S, Picariello G, Ferranti P, Barkholt V. 2005. Caseinomacropeptide self-association is dependent on whether the peptide is free or restricted in kappa-casein. J Dairy Sci 88 (12 4228 38. (Pubitemid 41810249)
10. Ney D, Gleason S, van Calcar S, MacLeod E, Nelson K, Etzel M, Rice G, Wolff J. 2008a. Nutritional management of PKU with glycomacropeptide from cheese whey. J Inherit Metab Dis. DOI.
11. Ney D, Hull A, van Calcar S, Liu X, Etzel M. 2008b. Dietary glycomacropeptide supports growth and reduces the concentrations of phenylalanine in plasma and brain in a murine model of phenylketonuria (1,2). J Nutr 138 : 316 22.
12. Nielsen SS. 2003. Food analysis. 3rd ed. New York : Kluwer Academic/Plenum Publishers.
13. Pietz J, Kreis R, Rupp A, Mayatepek E, Rating D, Boesch C, Bremer HJ. 1999. Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria. J Clin Invest 103 (8 1169 78. (Pubitemid 29207251)
14. Poustie V, Rutherford P. 2000. Tyrosine supplementation for phenylketonuria. Cochrane Db Syst Rev (2 CD001507.
15. Rutherford P, Poustie V. 2005. Protein substitute for children and adults with phenylketonuria. Cochrane Db Syst Rev (4 CD004731.
16. Scriver CR. 2001. The metabolic & molecular bases of inherited disease. 8th ed. New York : McGraw-Hill.
17. Shaw V, Lawson M. 1994. Clinical paediatric dietetics. Oxford, Boston, Mass Blackwell Scientific.
18. Smith I, Cockburn F, Barwell B, Brenton D, Chapple J, Clark B, Curzon G, Davidson D, Heeley A, Laing S, Listercheese I, McDonald I, Malcolm S, Pollitt R, Quinn D, Rylance G, Stewart A, Surtees R, Thompson A, Tyfield L, Whittle M, Scriver C, Frew J. 1993. Recommendations on the dietary-management of phenylketonuria. Arch Dis Child 68 (3 426 7.
19. Spronsen Fv, Rijn Mv, Bekhof J, Koch R, Smit P. 2001. Phenylketonuria: tyrosine supplementation in phenylalanine-restricted diets. Am J Clin Nutr 73 (2 153 7. (Pubitemid 32109842)
20. Tek H, Turhan K, Etzel M. 2005. Effect of conductivity, pH, and elution buffer salinity on glycomacropeptide recovery from whey using anion exchange chromatography. J Food Sci 70 (4 E295 E300. (Pubitemid 40722324)
21. Thoma-Worringer C, Sorensen J, Lopez-Findino R. 2006. Health effects and technological features of caseinomacropeptide. Int Dairy J 16 (11 1324 33. (Pubitemid 44348878)
22. van Calcar S, MacLeod E, Gleason S, Etzel M, Clayton M, Wolff J, Ney D. 2009. Improved nutritional management of phenylketonuria using a diet containing glycomacropeptide compared with amino acids. Am J Clin Nutr (Forthcoming).
23. Walstra P, Wouters JTM, Geurts TJ. 2006. Dairy science and technology. 2nd ed. Boca Raton, Fla. : CRC/Taylor & Francis.
24. Weetch E, MacDonald A. 2006. The determination of phenylalanine content of foods suitable for phenylketonuria. J Hum Nutr Diet 19 (3 229 36. (Pubitemid 44349292)